Taysha Gene Therapies (TSHA) Stock Price & Financial Analysis
Taysha Gene Therapies Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Taysha Gene Therapies
What is the current stock price for TSHA?
As of the latest trading session, TSHA stock trades at $5.45. The 52-week range is $2.21–$7.30, with a day range of $5.36–$6.04.
What is the P/E ratio for TSHA?
The P/E ratio (Price-to-Earnings) for TSHA is shown in the Key Statistics section. This valuation metric helps compare Taysha Gene Therapies, Inc. to industry peers.
Does TSHA pay dividends?
Taysha Gene Therapies does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for TSHA?
Based on 3 analysts, the consensus for TSHA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of TSHA?
Taysha Gene Therapies's market capitalization is $1.74B, classifying it as a small-cap company. Taysha Gene Therapies operates in the Healthcare sector within the Biotechnology industry.